Received Feb 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | X019301 | — |
No adverse side effects were reported. No additional information available at this time.; HCP called regarding an PROQUAD vaccine that expired 1/14/2025 and was administered to a patient on 2/1/2025; This spontaneous report was received from a medical assistant referring to a 4-year-old male patient. The patient's medical history, historical drugs, past drug reactions or allergies, concurrent conditions, and concomitant drugs were not reported. On 01-FEB-2025, the patient was vaccinated with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (rHA) (PROQUAD) injection (lot#: X019301, expiration date: 14-JAN-2025; strength, dose, and route of administration were not reported) by a healthcare professional for prophylaxis (expired product administered). No adverse event occurred.